March 19 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK:
FY NET PROFIT ATTRIBUTABLE FOR JIANGZHONG PHARMACEUTICAL RMB788.2 MILLION
FY REVENUE FOR JIANGZHONG PHARMACEUTICAL RMB4.44 BILLION
CASH DIVIDEND OF RMB7.00 FOR EVERY 10 SHARES OF JIANGZHONG PHARMACEUTICAL
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))